Bafna Pharmaceuticals Limited (BOM:532989)

India · Delayed Price · Currency is INR

247.00

+4.80 (1.98%)

At close: Aug 21, 2026

Bafna Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	1,426	1,506	1,459	1,525	1,153	851.4
Revenue Growth	-3.14%	3.26%	-4.33%	32.18%	35.48%	19.55%
Gross Profit	450.12	481.34	424.19	452.15	383.38	336
Operating Income	52.77	98.75	69.49	73.36	117.72	66.41
Net Income	77.86	111	41.53	73.48	113.38	52.16
Earnings Per Share	3.24	4.69	1.76	3.11	4.79	2.21
EPS Growth	-7.03%	167.18%	-43.49%	-35.15%	117.23%	-10.36%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	720.34	567.39	255.45	269.89
Export	729.78	941.98	885.09	547.65
Unallocated	8.45	15.28	12.97	33.87
Total	1,459	1,525	1,153	851.4

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	20.25	20.25	34.33	13.96	78.09	1.73
Total Debt	374.33	374.33	281.99	243.89	229.24	110.59
Net Cash (Debt)	-354.09	-354.09	-247.66	-229.93	-151.15	-108.86
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-14.75	-14.96	-10.47	-9.72	-6.39	-4.60

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	153.71	221.36	94.85	49.53	97.28
Capital Expenditures	-	-249.03	-218.6	-155.78	-67.19	-75.41
Free Cash Flow	-	-95.32	2.76	-60.93	-17.66	21.87
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	31.57%	31.96%	29.08%	29.66%	33.24%	39.46%
Operating Margin	3.70%	6.56%	4.76%	4.81%	10.21%	7.80%
Pretax Margin	5.37%	7.28%	2.85%	4.82%	10.07%	6.13%
Profit Margin	5.46%	7.37%	2.85%	4.82%	9.83%	6.13%
FCF Margin	-	-6.33%	0.19%	-4.00%	-1.53%	2.57%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 23, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	73.66	23.30	42.61	25.23	17.11	57.44
P/FCF Ratio	-	-	640.66	-	-	136.99
PS Ratio	4.02	1.72	1.21	1.22	1.68	3.52